{
  "trial_id": "NCT00433589",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "High-risk of recurrence according to both the clinical-pathological criteria and the 70-gene signature",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Endocrine-responsive disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Hormone receptor-positive disease (estrogen receptor-positive, progesterone receptor-positive, or both)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Female",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "WHO performance status 0-1",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Neutrophil count > 1,500/mm^3",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Platelet count > 100,000/mm^3",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Creatinine clearance at least 50 mL/min OR creatinine up to 1.5 times upper limit of normal (ULN)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ALT and AST up to 2.5 times ULN",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Alkaline phosphatase up to 2.5 times ULN",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Bilirubin up to 2.0 times ULN",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Normal echocardiogram (ECHO) compatible with chemotherapy treatment",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of documented congestive heart failure",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "High-risk uncontrolled arrhythmias",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Angina pectoris requiring antianginal medication",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Clinically significant valvular heart disease",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Evidence of transmural infarction on ECG",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Poorly controlled hypertension (e.g., systolic blood pressure [BP] > 180 mm Hg or diastolic BP > 100 mm Hg)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Symptomatic coronary artery disease or a myocardial infarction within the past 12 months",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Other risk factors that contraindicate the use of anthracycline-based chemotherapy",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer. A core biopsy revealed a 3 cm invasive ductal breast carcinoma in the left upper outer quadrant.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT00433589",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}